BRO vs VIR · P/E 30, rev $4.80B vs rev $74.2M
Brown & Brown Inc (BRO) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. VIR currently screens at market cap $1.45B.
Not investment advice. Open the BRO and VIR stock pages for the full models.
Not investment advice.